Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Pm to Mazan. - A little early? But something to think about.
13
Oct 31, 2016 09:04AM
9
Oct 31, 2016 09:48AM
17
Oct 31, 2016 09:55AM

Oct 31, 2016 09:59AM

When the heck are they going to get this Pm working?

PM to Mazan: Apologies to the rest of the Agora Board. Carry On

Mazan, are you still here? How do you feel about the latest BOD actions? Pissed?

I think you need 5% of outstanding shares to send a message to our BOD for a vote on any subject/issue. Take your pick. Got a few buddy’s to make this work? Not sure of the costs involved or how this can be done. I would like to see news release published on all news outlets, and having them to address this.

We need to have a voice with these characters. That is after a week or so allowing them to answer why they did such a dumb thing. (Loss of XXX million market cap for 12 million, + those warrants). Just a thought, even if it would wake up our BOD.

Not sure if a group with a combined total of greater than 5% can do this.

Here is an example sample letter to canexus when Stirling has had enough. Cut and paste Poet issues, but you get the idea.

EGREGIOUS SHAREHOLDER VALUE DESTRUCTION

LONDON, Sept. 15, 2016 /CNW/ - Stirling Funds are a family of global value-focused funds that invest with the objective of achieving long-term capital appreciation. Stirling Funds are holders of greater than 5% of the outstanding shares of Canexus Corp.

Stirling Funds are troubled with the conduct of the Canexus Board of directors and management in not fulfilling their fiduciary duties to maximize value for all stakeholders.

Let's examine the facts:

Canexus was not able to secure a reverse break fee in the failed Superior Plus Corp transaction.

Chemtrade Logistics Income Fund (TSX: CHE.UN) has expressed interest in acquiring Canexus "at the right price". Canexus has ostensibly not explored this interest and rather it has embarked on a convertible debenture making the company less attractive to potential suiters thereby destroying shareholder value.

Stirling Funds is considering remedies on behalf of all shareholders including but not limited to calling a special meeting.

SOURCE The Stirling Funds

For further information: The Stirling Funds, London, England, Gordon Flatt, Chief Investment Officer, +44 3239 9932, info@stirling-funds.co.uk

For further information: The Stirling Funds, London, England, Gordon Flatt, Chief Investment Officer, +44 3239 9932, info@stirling-funds.co.uk

SOURCE The Stirling Funds For further information: The Stirling Funds, London, England, Gordon Flatt, Chief Investment Officer, +44 3239 9932, info@stirling-funds.co.uk

3
Oct 31, 2016 12:12PM
Share
New Message
Please login to post a reply